Related Experiment Video
Updated: Oct 27, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
The Effect of Sodium Thiosulfate on Coronary Artery Calcification in Hemodialysis Patients
Zhixiang Bian1, Qin Zhang, Li Shen
1From the Department of Nephrology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Insights
Sodium thiosulfate effectively reduced coronary artery calcification (CAC) and improved symptoms in hemodialysis patients with secondary hyperparathyroidism. Routine treatment alone did not significantly alter these markers.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Endocrinology
Background:
- Secondary hyperparathyroidism is a common complication in hemodialysis patients.
- Vascular calcification, particularly coronary artery calcification (CAC), is a significant predictor of cardiovascular morbidity and mortality in this population.
- Effective management strategies are needed to control disease progression and improve patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of sodium thiosulfate in managing secondary hyperparathyroidism in hemodialysis outpatients.
- To assess the impact of sodium thiosulfate on serum markers, coronary artery calcification (CAC) scores, and clinical symptoms.
- To compare the outcomes of sodium thiosulfate treatment with routine care.
Main Methods:
- A randomized controlled trial design was employed, dividing patients into a control group (routine treatment) and a treatment group (routine treatment plus sodium thiosulfate).
- Serum levels of calcium, phosphorus, parathyroid hormone (PTH), and C-reactive protein were monitored.
- Coronary artery calcification (CAC) scores were assessed using imaging techniques.
- Clinical symptoms such as skin pruritus, myasthenia, bone pain, insomnia, and restless legs syndrome were evaluated pre- and post-treatment.
Main Results:
- The treatment group showed significant reductions in C-reactive protein levels and CAC scores post-intervention.
- No significant changes in serum calcium, phosphorus, PTH, calcium-phosphorus product, or CAC scores were observed in the control group.
- The incidence of clinical symptoms significantly decreased in the sodium thiosulfate group compared to baseline, while the control group showed no significant improvement.
Conclusions:
- Sodium thiosulfate demonstrates a clear benefit in reducing elevated CAC levels in hemodialysis patients.
- This treatment approach effectively alleviates common clinical symptoms associated with secondary hyperparathyroidism in this cohort.
- Sodium thiosulfate represents a promising therapeutic option for managing cardiovascular complications in hemodialysis patients.
Abstract:
This study aimed to effectively control the disease process of hemodialysis outpatients. Hemodialysis secondary hyperparathyroidism patients were randomly divided into the control group and treatment group. The control group was treated with routine treatment, and the treatment group was treated with sodium thiosulfate based on the control group. The changes of serum calcium, phosphorus, whole parathyroid hormone, calcium-phosphorus product and coronary artery calcification (CAC) score, as well as the relief of clinical symptoms, postoperative complications and recurrence in the preoperative and postoperative periods were observed. The levels of C-reactive protein and CAC scores were significantly decreased in the treatment group after treatment. While there was no significant difference in blood calcium, blood phosphorus, PTH, calcium-phosphorus product, and CAC score in the control group after treatment. And after treatment, the proportion of skin pruritus, myasthenia, bone pain, insomnia, restless legs syndrome, and other symptoms in the treatment group was significantly decreased compared with those before treatment, but there was no significant change in the control group before and after treatment. Sodium thiosulfate can reduce the high level of CAC in hemodialysis patients obviously.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Antihypertensive Drugs: Thiazide-Class Diuretics
Coronary Artery Disease II: Pathophysiology
Hemodialysis I: Introduction